Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 18.84% vs -7.32% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 37.40% vs 9.05% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 28.16% vs 12.67% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -93.58% vs 395.45% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 18.84% vs -7.32% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.53% vs 34.34% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 37.40% vs 9.05% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 25.12% vs 94.95% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 28.16% vs 12.67% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 28.01% vs 91.33% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -93.58% vs 395.45% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -78.79% vs 22.22% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






